Sienna Biopharmaceuticals Current Cash

Sienna Biopharmaceuticals (SNNAQ) currently reports a current cash of $11M as of September 2019. That compares with $64M in the prior-year period — down 82.3% year over year. Use the charts on this page to explore Sienna Biopharmaceuticals's current cash history and peer comparisons.

Sienna Biopharmaceuticals's current cash decreased from $64M to $11M — a 82.3% year-over-year decrease (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sienna Biopharmaceuticals reported $11M in current cash as of September 2019. That compares with $64M in the prior-year period — down 82.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sienna Biopharmaceuticals, and consider following SNNAQ for alerts when major investors trade the stock.

Sienna Biopharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNNAQ with unrelated industries.